T. Rowe Price Associates
EVHC

T. Rowe Price Associates’s Envision Healthcare Holdings Inc EVHC Stock Holding History

T. Rowe Price Associates’s Portfolio EVHC Stock Details EVHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,098,214
Closed -$325M – 2641
2018
Q3 		$325M Sell
7,098,214
-4,968,748
-41% -$223M 0.05% 368
2018
Q2 		$531M Sell
12,066,962
-2,598,499
-18% -$107M 0.08% 241
2018
Q1 		$564M Sell
14,665,461
-1,750,379
-11% -$65.4M 0.09% 229
2017
Q4 		$567M Buy
16,415,840
+1,088,417
+7% +$38.1M 0.09% 233
2017
Q3 		$689M Buy
15,327,423
+2,024,145
+15% +$108M 0.12% 185
2017
Q2 		$834M Buy
13,303,278
+3,070,509
+30% +$177M 0.15% 158
2017
Q1 		$627M Buy
10,232,769
+3,744,749
+58% +$251M 0.12% 202
2016
Q4 		$411M Buy
6,488,020
+2,218,089
+52% +$145M 0.08% 268
2016
Q3 		$285M Buy
4,269,931
+1,771,143
+71% +$122M 0.06% 326
2016
Q2 		$190M Sell
2,498,788
-175,440
-7% -$12.5M 0.04% 421
2016
Q1 		$163M Buy
2,674,228
+275,784
+11% +$18.1M 0.03% 439
2015
Q4 		$186M Buy
2,398,444
+111,382
+5% +$9.63M 0.04% 418
2015
Q3 		$252M Sell
2,287,062
-54,044
-2% -$6.69M 0.06% 357
2015
Q2 		$277M Buy
2,341,106
+13,326
+0.6% +$1.52M 0.06% 358
2015
Q1 		$267M Buy
2,327,780
+188,176
+9% +$20.5M 0.06% 373
2014
Q4 		$222M Buy
2,139,604
+170,564
+9% +$17.6M 0.05% 408
2014
Q3 		$204M Buy
1,969,040
+37,518
+2% +$3.98M 0.04% 417
2014
Q2 		$208M Buy
1,931,522
+139,245
+8% +$14.3M 0.04% 428
2014
Q1 		$182M Buy
1,792,277
+680,725
+61% +$68.1M 0.04% 457
2013
Q4 		$118M Sell
1,111,552
-187,307
-14% -$16.9M 0.03% 572
2013
Q3 		$101M Buy
+1,298,859
New +$103M 0.03% 591

Other funds holding EVHC

SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

T. Rowe Price Associates's EVHC Position: Q4 2018 in Review

T. Rowe Price Associates sold out of Envision Healthcare Holdings Inc (EVHC) in Q4 2018, closing a stake of 7,098,214 shares — an estimated $325M sold.

T. Rowe Price Associates first reported a position in EVHC in Q3 2013 and held it in 21 quarters. The position peaked at $834M in Q2 2017. 4 funds tracked by Wall St. Rank hold EVHC as of Q4 2018.

  • T. Rowe Price Associates reported no remaining Envision Healthcare Holdings Inc position as of Q4 2018 after selling out during the quarter.
  • T. Rowe Price Associates sold 7,098,214 Envision Healthcare Holdings Inc shares in Q4 2018, an estimated $325M.
  • T. Rowe Price Associates first reported a position in Envision Healthcare Holdings Inc in Q3 2013 and held it in 21 quarters.
  • T. Rowe Price Associates's Envision Healthcare Holdings Inc position peaked at $834M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Envision Healthcare Holdings Inc as of Q4 2018.

Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.